Citation: H. Toss et al., Effects of low-molecular-weight heparin treatment on fibrinolytic markers in unstable coronary artery disease, FIBRINOL PR, 15(1), 2001, pp. 26-31
Authors:
Lindmark, E
Diderholm, E
Wallentin, L
Siegbahn, A
Citation: E. Lindmark et al., Relationship between interleukin 6 and mortality in patients with unstablecoronary artery disease - Effects of an early invasive or noninvasive strategy, J AM MED A, 286(17), 2001, pp. 2107-2113
Citation: E. Lindmark et al., Blood cell activation, coagulation, and inflammation in men and women withcoronary artery disease, THROMB RES, 103(3), 2001, pp. 249-259
Authors:
Olsson, C
Siegbahn, A
Henze, A
Nilsson, B
Venge, P
Joachimsson, PO
Thelin, S
Citation: C. Olsson et al., Heparin-coated cardiopulmonary bypass circuits reduce circulating complement factors and interleukin-6 in paediatric heart surgery, SC CARDIOVA, 34(1), 2000, pp. 33-40
Citation: E. Lindmark et al., Role of platelet P-selectin and CD40 ligand in the induction of monocytic tissue factor expression, ART THROM V, 20(10), 2000, pp. 2322-2328
Citation: Ne. Nielsen et al., Markers of hypercoagulation and von Willebrand factor in postmenopausal women with unstable coronary artery disease. Discriminatory ability regardingunstable coronary artery disease and coronary atherosclerosis using receiver operating characteristics, J INTERN M, 248(2), 2000, pp. 151-158
Authors:
Lindberg, F
Rasmussen, I
Siegbahn, A
Bergqvist, D
Citation: F. Lindberg et al., Coagulation activation after laparoscopic cholecystectomy in spite of thromboembolism prophylaxis, SURG ENDOSC, 14(9), 2000, pp. 858-861
Authors:
Lindahl, B
Toss, H
Siegbahn, A
Venge, P
Wallentin, L
Citation: B. Lindahl et al., Markers of myocardial damage and inflammation in relation to long-term mortality in unstable coronary artery disease., N ENG J MED, 343(16), 2000, pp. 1139-1147
Authors:
Siegbahn, A
Johnell, M
Rorsman, C
Ezban, M
Heldin, CH
Ronnstrand, L
Citation: A. Siegbahn et al., Binding of factor VIIa to tissue factor on human fibroblasts leads to activation of phospholipase C and enhanced PDGF-BB-stimulated chemotaxis, BLOOD, 96(10), 2000, pp. 3452-3458
Authors:
Olsson, C
Siegbahn, A
Halden, E
Nilsson, B
Venge, P
Thelin, S
Citation: C. Olsson et al., No benefit of reduced heparinization in thoracic aortic operation with heparin-coated bypass circuits, ANN THORAC, 69(3), 2000, pp. 743-749
Authors:
Holmberg, A
Siegbahn, A
Westman, B
Bergqvist, D
Citation: A. Holmberg et al., Ischaemia and reperfusion during open abdominal aortic aneurysm surgery induce extensive thrombin generation and activity, EUR J VAS E, 18(1), 1999, pp. 11-16
Authors:
Holmberg, A
Bergqvist, D
Westman, B
Siegbahn, A
Citation: A. Holmberg et al., Cytokine and fibrinogen response in patients undergoing open abdominal aortic aneurysm surgery, EUR J VAS E, 17(4), 1999, pp. 294-300
Citation: T. Tenno et al., Induction of differentiation in U-937 and NB4 cells is associated with inhibition of tissue factor production, EUR J HAEMA, 63(2), 1999, pp. 112-119
Authors:
Frostfeldt, G
Ahlberg, G
Gustafsson, G
Helmius, G
Lindahl, B
Nygren, A
Siegbahn, A
Swahn, E
Venge, P
Wallentin, L
Citation: G. Frostfeldt et al., Low molecular weight heparin (dalteparin) as adjuvant treatment to thrombolysis in acute myocardial infarction - A pilot study: Biochemical markers in acute coronary syndromes (BIOMACS II), J AM COL C, 33(3), 1999, pp. 627-633
Authors:
Linder, R
Oldgren, J
Egberg, N
Grip, L
Larson, G
Siegbahn, A
Wallentin, L
Citation: R. Linder et al., The effect of a low molecular mass thrombin inhibitor, inogatran, and heparin on thrombin generation and fibrin turnover in patients with unstable coronary artery disease, EUR HEART J, 20(7), 1999, pp. 506-518
Authors:
Oldgren, J
Linder, R
Grip, L
Siegbahn, A
Wallentin, L
Citation: J. Oldgren et al., Activated partial thromboplastin time and clinical outcome after thrombin inhibition in unstable coronary artery disease, EUR HEART J, 20(22), 1999, pp. 1657-1666
Authors:
Wallentin, L
Swahn, E
Kontny, F
Husted, S
Lagerqvist, B
Stahle, E
Nielsen, JD
Dellborg, M
Geiran, O
Grande, P
Hulting, J
Kyst-Madsen, J
Nordrehaug, JE
Naslund, U
Pilegaard, H
Rollag, A
Nielsen, TT
Saetre, H
Siegbahn, A
Ohlin, H
Arbeus, M
Bylund, H
Ekstrom, SL
Eriksson, GP
Geiran, O
Holmgren, A
Kellerth, T
Kyst-Madsen, J
Lindblom, D
Lindvall, B
Nordrehaug, J
Pilegaard, H
Radegran, K
Sjogren, I
Stenport, G
Stahl, E
Svane, B
Svedjeholm, R
Toftegaard-Nielsen, T
Hassan, SY
Naslund, U
Persson, S
Jacobsson, KA
Thygesen, K
von der Lippe, G
Julian, D
Bertrand, M
Wedel, H
Andren, B
Diderholm, E
Frostfeldt, G
Jernberg, T
Dellborg, M
Abrahamsson, P
Lindahl, B
Jernberg, T
Siegbahn, A
Venge, P
Swahn, E
Janzon, M
Logander, E
Svensson, E
Lindstrom, G
Alsjo, G
Gulin, M
Setterberg, G
Wikstrom, L
Andersen, IM
Seim, T
Citation: L. Wallentin et al., Long-term low-molecular-mass heparin in unstable coronary-artery disease: FRISC II prospective randomised multicentre study, LANCET, 354(9180), 1999, pp. 701-707
Authors:
Wallentin, L
Swahn, E
Kontny, F
Husted, S
Lagerqvist, B
Stahle, E
Nielsen, JD
Dellborg, M
Geiran, O
Grande, P
Hulting, J
Kyst-Madsen, J
Nordrehaug, JE
Naslund, U
Pilegaard, H
Rollag, A
Nielsen, TT
Saetre, H
Siegbahn, A
Ohlin, H
Lagerqvist, B
Arbeus, M
Bylund, H
Ekstrom, L
Eriksson, P
Geiran, O
Holmgren, A
Kellerth, T
Kyst-Madsen, J
Lindblom, D
Lindvall, B
Nordrehaug, J
Pilegaard, H
Radegran, K
Sjogren, I
Stenport, G
Stahl, E
Svane, B
Svedjeholm, R
Toftegaard-Nielsen, T
Hassan, SY
Naslund, U
Persson, S
Jacobsson, KA
Thygesen, K
von der Lippe, G
Julian, D
Bertrand, M
Wedel, H
Andren, B
Diderholm, E
Frostfeldt, G
Jernberg, T
Dellborg, M
Abrahamsson, P
Lindahl, B
Jernberg, T
Siegbahn, A
Venge, P
Swahn, E
Janzon, M
Logander, E
Svensson, E
Lindstrom, G
Alsjo, G
Gulin, M
Setterberg, G
Wikstrom, L
M-Andersen, I
Seim, T
Citation: L. Wallentin et al., Invasive compared with non-invasive treatment in unstable coronary-artery disease: FRISC II prospective randomised multicentre study, LANCET, 354(9180), 1999, pp. 708-715
Citation: A. Holmberg et al., Coagulation and fibrinolysis after open infrarenal abdominal aortic aneurysm repair in a long-term perspective, THROMB RES, 96(2), 1999, pp. 99-105